ADCY4 and diabetic kidney disease: ADCY4 (53) and GNAS (54) are both involved in the cAMP signaling pathway, which plays an important role in glucose metabolism (55), inflammation (41), and fibrosis (56), as well as in diabetic kidney disease (57), diabetic retinopathy (58), and neuropathy (59).